BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21343296)

  • 21. The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.
    Wang Y; Cui M; Cai X; Sun B; Liu F; Zhang X; Ye L
    Cancer Lett; 2014 Oct; 352(2):169-78. PubMed ID: 24882622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer.
    Li S; Zhang H; Ning T; Wang X; Liu R; Yang H; Han Y; Deng T; Zhou L; Zhang L; Bai M; Wang X; Ge S; Ying G; Ba Y
    Cell Physiol Biochem; 2016; 40(6):1303-1315. PubMed ID: 27997901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation.
    Li L; Liu B; Zhang X; Ye L
    Biochem Biophys Res Commun; 2015 Mar; 458(3):720-725. PubMed ID: 25686500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-520b inhibits endothelial activation by targeting NF-κB p65-VCAM1 axis.
    Yang B; Yang H; Lu X; Wang L; Li H; Chen S; Wang X; Shen C; Huang J; Lu X; Gu D
    Biochem Pharmacol; 2021 Jun; 188():114540. PubMed ID: 33819467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
    Dong Y; Liu Y; Jiang A; Li R; Yin M; Wang Y
    Mol Cell Biochem; 2018 Feb; 439(1-2):95-104. PubMed ID: 28795314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
    Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion.
    Niu J; Shi Y; Tan G; Yang CH; Fan M; Pfeffer LM; Wu ZH
    J Biol Chem; 2012 Jun; 287(26):21783-95. PubMed ID: 22547075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
    Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
    Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2.
    Wu T; Song H; Xie D; Hua K; Hu J; Deng Y; Ji C; Fang L
    Biomed Res Int; 2020; 2020():7907269. PubMed ID: 32420372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
    Lin L; Liu D; Liang H; Xue L; Su C; Liu M
    Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
    Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
    Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
    Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
    Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
    Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
    Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.
    Hurst DR; Edmonds MD; Scott GK; Benz CC; Vaidya KS; Welch DR
    Cancer Res; 2009 Feb; 69(4):1279-83. PubMed ID: 19190326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
    Li D; Song H; Wu T; Xie D; Hu J; Zhao J; Shen Q; Fang L
    Mol Cell Biochem; 2018 Jul; 444(1-2):169-178. PubMed ID: 29188531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
    Zhang ZG; Chen WX; Wu YH; Liang HF; Zhang BX
    Biochem Biophys Res Commun; 2014 Nov; 454(1):109-14. PubMed ID: 25450365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.